3 Penny Stocks With Market Caps At Least US$70M To Watch

Global markets have been experiencing a turbulent start to the year, with U.S. equities facing pressure from inflation concerns and political uncertainty, while small-cap stocks continue to lag behind their larger counterparts. Amidst this volatility, investors are increasingly looking at alternative investment opportunities that may offer growth potential despite broader market challenges. Penny stocks, though often seen as speculative plays, can present unique opportunities when backed by strong financials and fundamentals. These smaller or younger companies might not grab headlines but can offer value and growth prospects that larger firms sometimes miss.

Top 10 Penny Stocks

Name	Share Price	Market Cap	Financial Health Rating
DXN Holdings Bhd (KLSE:DXN)	MYR0.505	MYR2.51B	★★★★★★
Polar Capital Holdings (AIM:POLR)	£4.825	£465.11M	★★★★★★
Embark Early Education (ASX:EVO)	A$0.77	A$141.28M	★★★★☆☆
Foresight Group Holdings (LSE:FSG)	£3.55	£405.37M	★★★★★★
LaserBond (ASX:LBL)	A$0.56	A$65.64M	★★★★★★
Hil Industries Berhad (KLSE:HIL)	MYR0.885	MYR293.77M	★★★★★★
Lever Style (SEHK:1346)	HK$0.83	HK$526.87M	★★★★★★
Stelrad Group (LSE:SRAD)	£1.42	£180.84M	★★★★★☆
Secure Trust Bank (LSE:STB)	£3.53	£67.32M	★★★★☆☆
Starflex (SET:SFLEX)	THB2.58	THB2B	★★★★☆☆

Click here to see the full list of 5,703 stocks from our Penny Stocks screener.

Let's take a closer look at a couple of our picks from the screened companies.

Yunhong Guixin Group Holdings (SEHK:8349)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Yunhong Guixin Group Holdings Limited is an investment holding company involved in the research, development, production, and sale of fiberglass reinforced plastic products in China, with a market cap of HK$568 million.

Operations: The company's revenue primarily comes from its Fiberglass Business, which generated CN¥36.44 million.

Market Cap: HK$568M

Yunhong Guixin Group Holdings, with a market cap of HK$568 million, focuses on fiberglass reinforced plastic products in China. Despite being unprofitable and having experienced management and board teams, the company has no debt and its short-term assets cover both short- and long-term liabilities. Recent developments include obtaining prospecting licenses for mining areas in Burkina Faso, indicating potential diversification into mining. However, the company faced an auditor change due to fee disagreements and saw board changes with new appointments enhancing expertise in human resources and finance. The company's stock remains highly volatile compared to other Hong Kong stocks.

• Get an in-depth perspective on Yunhong Guixin Group Holdings' performance by reading our balance sheet health report here.
• Gain insights into Yunhong Guixin Group Holdings' past trends and performance with our report on the company's historical track record.

Zhejiang Zhongcheng Packing Material (SZSE:002522)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Zhejiang Zhongcheng Packing Material Co., Ltd. operates in the packaging materials industry with a market capitalization of CN¥3.46 billion.

Operations: Zhejiang Zhongcheng Packing Material Co., Ltd. does not report distinct revenue segments.

Market Cap: CN¥3.46B

Zhejiang Zhongcheng Packing Material, with a market cap of CN¥3.46 billion, operates in the packaging materials industry and shows a satisfactory net debt to equity ratio of 12.2%, indicating manageable leverage. Despite an experienced management team and board, earnings have declined by 1.4% annually over five years, with recent negative growth impacting profitability. The company’s interest payments are well covered by EBIT at 4.2 times coverage, but profit margins have decreased from 6.1% to 3.6%. Recent results show reduced revenue and net income compared to the previous year, highlighting ongoing financial challenges amidst stable weekly volatility.

• Unlock comprehensive insights into our analysis of Zhejiang Zhongcheng Packing Material stock in this financial health report.
• Examine Zhejiang Zhongcheng Packing Material's past performance report to understand how it has performed in prior years.

Youngy Health (SZSE:300247)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Youngy Health Co., Ltd. is a company that manufactures, exports, and sells sauna products in China with a market cap of CN¥2.87 billion.

Operations: Youngy Health Co., Ltd. has not reported any specific revenue segments.

Market Cap: CN¥2.87B

Youngy Health Co., Ltd. has demonstrated significant growth, with earnings increasing by 169.9% over the past year, surpassing the Leisure industry average. The company is debt-free and maintains a robust financial position, with short-term assets of CN¥876.1 million covering both short and long-term liabilities comfortably. However, its return on equity remains low at 4.8%, and recent financial results were influenced by a large one-off gain of CN¥17.5 million. Despite stable weekly volatility over the past year, Youngy Health's share price has been highly volatile in recent months, which is common among stocks in this category.

• Dive into the specifics of Youngy Health here with our thorough balance sheet health report.
• Gain insights into Youngy Health's historical outcomes by reviewing our past performance report.

Make It Happen

• Reveal the 5,703 hidden gems among our Penny Stocks screener with a single click here.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com